Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...

Experts emphasized that obesity is a chronic, relapsing condition and lifelong therapy—in some form—will be necessary.

The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.

Better devices and changes in implant depth have likely led to fewer LBBBs over time, but the issue needs continued attention ...

The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

The disparate cutoffs may help determine whether a patient should go to the cath lab. Prospective validation comes next.

Interventional cardiologists say some cases that coders flag and submit to the NCDR aren’t in fact problematic.

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, ...

Cardiovascular imaging, which continues to evolve alongside interventions and other technologies, made notable strides in the ...

Gene-editing therapy, ACS guidelines, and the death of Dimitrios Karmpaliotis were some of TCTMD’s most-read stories this ...

The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.